Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.76%
#4 aPriori aPriori +108.27%
#5 Bedrock Bedrock +74.39%
#6 Cysic Cysic +49.09%
#7 Prom Prom +38.71%
#8 Playnance Playnance +35.10%
#9 COTI COTI +26.15%
#10 Nillion Nillion +24.13%
Coin of the day
Wrapped One Wrapped One
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
TetraLogic Pharmaceuticals Corporation TetraLogic Pharmaceuticals Corporation

TetraLogic Pharmaceuticals Corporation

TLOG
Classement en actions #42528
TetraLogic Pharmaceuticals Corporation operates as a clinical-stage... TetraLogic Pharmaceuticals Corporation operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on identifying and advancing small-molecule treatments for cancer and infectious diseases. The company's development pipeline features two key clinical-stage drug candidates: birinapant and SHAPE. Birinapant, a small molecule, functions as a Second Mitochondrial Activator of Caspases (SMAC) mimetic, promoting programmed cell death, or apoptosis, in compromised cells. SHAPE, another proprietary compound, is a histone deacetylase (HDAC) inhibitor intended for topical administration to address early-stage cutaneous T-cell lymphoma. Furthermore, TetraLogic Pharmaceuticals has a research collaboration with the Walter and Eliza Hall Institute of Medical Research to explore the application of SMAC-mimetics, including birinapant, in treating infectious diseases. Founded in 2001 as Gentara Corporation, the company adopted its current name, TetraLogic Pharmaceuticals Corporation, in January 2006 and maintains its headquarters in Malvern, Pennsylvania.
Prix de l'action
$0.00004
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$979.00
Changement (1 jour)
0.00%
Changement (1 an)
-60.00%
Pays
US
Échange TetraLogic Pharmaceuticals Corporation (TLOG)

Catégorie

Healthcare
Historique du prix de l'action pour TetraLogic Pharmaceuticals Corporation (TLOG)
Prix de clôture le plus élevé : $0.00 le 2026-08-01

Prix de clôture le plus bas : $7.80 le 2013-12-01
Historique du prix de l'action de TetraLogic Pharmaceuticals Corporation de 2013 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 0.00%
2025 17.69%
2024 -14.40%
2023 -62.44%
2022 -94.10%
2021 -63.46%
2020 -64.19%
2019 262.70%
2018 -72.55%
2017 -41.80%
2016 -96.37%
2015 -69.79%
2014 -34.13%
2013 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 36.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 37.02%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 8.73%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 20.45%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -5.56%
KR